Pramila Jayapal addresses transparency, arms sales policy, and budget cuts in recent statements

Pramila Jayapal U.S. House of Representatives from Washington%27s 7th district - Official U.S. House Headshot
Pramila Jayapal U.S. House of Representatives from Washington's 7th district - Official U.S. House Headshot
0Comments

U.S. Representative Pramila Jayapal, who represents Washington’s 7th district in Congress, addressed several national issues in a series of posts on July 24, 2025.

In her first post of the day, Jayapal called for transparency regarding high-profile investigations, stating, “Trump can try to hide evidence and distract all he wants, but the American people deserve answers and will not back down. Release the Epstein files.” (July 24, 2025).

Later that afternoon, she referenced legislative efforts with fellow lawmaker Rep. Rashida Tlaib to limit arms sales to Israel: “Earlier this year, @RepRashida and I introduced resolutions to block the sale of specific offensive weapons to Israel. We need to respond to these atrocities with restraint and the assurance that any government will uphold U.S. law and international humanitarian law.” (July 24, 2025).

By evening, Jayapal highlighted concerns about proposed federal budget cuts: “Trump and Republicans’ rescissions package will impact nearly every corner of Washington State.” (July 24, 2025).

Jayapal has represented Washington’s 7th District since 2017 after succeeding Jim McDermott. Before her tenure in Congress, she served in the Washington State Senate from 2014 to 2016. Born in Chennai in 1965 and currently residing in Seattle at age 57, Jayapal holds degrees from Georgetown University and Northwestern University.



Related

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA

FDA inspects InnerSea Discoveries – Wilderness Discoverer, LLC in Seattle on July 21, 2024

On July 21, 2024, InnerSea Discoveries – Wilderness Discoverer, LLC in Seattle underwent an FDA inspection focused on food and cosmetics technical assistance, according to information available on the FDA’s website.

Mark Raza Principal Deputy Chief Counsel - FDA

Mark N. Fluchel, M.D. in Seattle scheduled for FDA inspection on Nov. 21, 2024

Mark N. Fluchel, M.D., based in Seattle, underwent an FDA bioresearch monitoring inspection on November 21, 2024, according to information available on the FDA’s website.

James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer

Kalsada Coffee Company in Seattle inspected by FDA on July 1, 2024

The Food and Drug Administration conducted an inspection of Kalsada Coffee Company in Seattle on July 1, 2024, focusing on foodborne biological hazards, according to FDA website data.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Seattle City Wire.